Alterola Biotech Stock Piotroski F Score

This module uses fundamental data of Alterola Biotech to approximate its Piotroski F score. Alterola Biotech F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Alterola Biotech. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Alterola Biotech financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
  
At this time, it appears that Alterola Biotech's Piotroski F Score is Inapplicable. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
0.0
Piotroski F Score - Inapplicable
Current Return On Assets

N/A

Focus
Change in Return on Assets

N/A

Focus
Cash Flow Return on Assets

N/A

Focus
Current Quality of Earnings (accrual)

N/A

Focus
Asset Turnover Growth

N/A

Focus
Current Ratio Change

N/A

Focus
Long Term Debt Over Assets Change

N/A

Focus
Change In Outstending Shares

N/A

Focus
Change in Gross Margin

N/A

Focus

Alterola Biotech Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Alterola Biotech is to make sure Alterola is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Alterola Biotech's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Alterola Biotech's financial numbers are properly reported.

About Alterola Biotech Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Currently Active Assets on Macroaxis

Other Information on Investing in Alterola Pink Sheet

Alterola Biotech financial ratios help investors to determine whether Alterola Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterola with respect to the benefits of owning Alterola Biotech security.